Reduction of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Rivaroxaban in ATLAS-ACS 2 TIMI 51

Author:

Gibson C. Michael,Chakrabarti Anjan K.,Mega Jessica,Bode Christophe,Bassand Jean-Pierre,Verheugt Freek W.A.,Bhatt Deepak L.,Goto Shinya,Cohen Marc,Mohanavelu Satishkumar,Burton Paul,Stone Gregg,Braunwald Eugene

Funder

Johnson & Johnson and Bayer Healthcare

Abbott, Bayer, Genentech, Ikaria, Johnson & Johnson, Merck, and The sanofi-aventis Group

Johnson & Johnson, Bayer Healthcare, Bristol-Myers Squibb, The sanofi-aventis Group, Daiichi Sankyo, and Eli Lilly

Actavis, Astellas, Bayer, Eli Lilly, GlaxoSmithKline, Medtronic, Merck, and The sanofi-aventis Group

Amarin, AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Medtronic, The sanofi-aventis Group, and The Medicines Company

The sanofi-aventis Group, Eisai, Boehringer Ingelheim, Otsuka, and Daiichi Sankyo

Johnson & Johnson and Daiichi Sankyo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Cited by 86 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3